Add BrightSurf on Google Email

Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

Researchers discovered that nine percent of esophageal adenocarcinoma patients harbor cancer-predisposing gene mutations, which may trigger progression from Barrett's esophagus. This finding supports the idea that genetic testing can help risk-stratify EAC patients and potentially accelerate development of new treatments.

SourceMass General Brigham·JournalGastroenterology·TypeObservational study·DateJul 26, 2023

First study to directly compare gene mutation type in individuals with CHAMP1 disorder indicates key differences

Researchers identified significant differences between individuals with CHAMP1 coding mutations and deletions, affecting adaptive functioning skills and severity of symptoms. The study highlights the importance of understanding genetic mechanisms to develop precision medicine approaches for treating CHAMP1 disorder.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalHuman Genetics·TypeObservational study·DateJul 17, 2023

Virus-like transposons wage war on the species barrier

Researchers from IMBA identify a family of virus-like transposons called Mavericks that facilitate horizontal gene transfer (HGT) between reproductively isolated worm species. The study reveals the role of Mavericks in overcoming the species barrier, with potential applications in pathogen control and genomic innovation.

New study reveals a potential big leap for gene therapy

A new study from Aarhus University has found that applying AI predictions of protein structures enhances the CRISPR technology, making the cuts in a patient's DNA more precise. This discovery may lead to better treatments for patients with genetic disorders and potentially develop cures for various genetic diseases.

SourceAarhus University·JournalCell·TypeExperimental study·DateJun 29, 2023

Research challenges current thinking on the genetic causes of very early menopause

A study published in Nature Medicine found that nearly all women carrying variations thought to cause very early menopause actually had their menopause at an older age, forcing a reevaluation of the genetic causes of the condition. The research suggests that premature menopause is likely caused by a combination of genetic and non-genet...

SourceUniversity of Exeter·JournalNature Medicine·TypeObservational study·DateJun 22, 2023

Which CFTR variants should be tested by laboratories? The ACMG releases updated carrier screening recommendations for cystic fibrosis

The American College of Medical Genetics and Genomics has released an updated minimum variant set of 100 CFTR gene variants for carrier screening, replacing the previous 23-variant list. The new recommendations apply to genetic testing to determine carrier status, not diagnosis or newborn screening.

SourceAmerican College of Medical Genetics and Genomics·JournalGenetics in Medicine·TypeContent analysis·DateJun 13, 2023

UW Medicine scientists among leads of NIH pangenome studies

The Human Pangenome Reference Consortium expands and updates the human genome project with nearly full genomic data from 47 people of diverse ancestry. Researchers at UW Medicine made significant contributions to drafting the pangenome reference and studying variation within repetitive DNA, which could improve equity in human genome re...

SourceUniversity of Washington School of Medicine/UW Medicine·JournalNature·TypeExperimental study·DateMay 10, 2023

Researchers overcome stem cell delivery barrier, paving the way for regenerative medicine

Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.

SourceXi'an Jiaotong-Liverpool University·JournalNano Letters·TypeExperimental study·DateMay 8, 2023

Gene responsible for severe facial defects identified

A team of researchers from UNIGE and Beihang University has identified the FOXI3 gene as responsible for one form of Goldenhar syndrome, a rare congenital disorder. Pathogenic variants in both copies of the FOXI3 gene are necessary for the disease to develop, following an autosomal recessive inheritance pattern.

SourceUniversité de Genève·JournalNature Communications·TypeNews article·DateMay 4, 2023

The ACMG publishes statement on clinical, technical and environmental biases influencing equitable access to clinical genetics/genomics testing

The American College of Medical Genetics and Genomics (ACMG) has published a statement addressing factors that contribute to bias in clinical genetic testing. The statement highlights three main areas: environmental, clinical, and technical biases, which affect health equity for individuals from historically marginalized populations.

SourceAmerican College of Medical Genetics and Genomics·JournalGenetics in Medicine·TypeLiterature review·DateApr 14, 2023

First-in-Canada clinical RNA sequencing platform may improve rare disease diagnostics in pediatrics

A new clinical RNA sequencing platform at SickKids is helping researchers understand complex genetic conditions and improve diagnosis for patients with rare diseases. The platform has been validated to be used in the clinical space, providing valuable diagnostic information that complements genome sequencing.

SourceThe Hospital for Sick Children·JournalAmerican Journal of Human Genetics·DateApr 13, 2023

5,500 people diagnosed with rare genetic diseases in major research study

A nationwide UK research study has diagnosed around 5,500 children with severe developmental disorders, identifying the genetic cause of their condition. The Deciphering Developmental Disorders study used genomic sequencing technology to provide diagnoses for families from across the UK and Ireland.

SourceUniversity of Exeter·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 12, 2023

Pathogenic genetic variations boost the risk of H. pylori-related stomach cancer

A large case-control study identified nine genes associated with stomach cancer risk and found that pathogenic genetic variations exacerbate the damage caused by H. pylori infection, significantly increasing the risk of gastric cancer. The study suggests that screening for pathogenic variants can help prioritize interventions.

SourceRIKEN·JournalNew England Journal of Medicine·TypeExperimental study·DateMar 29, 2023

Richard McIndoe, PhD, will direct Coordinating Unit for new, national research initiative in diabetes, obesity

Richard McIndoe is leading a national research initiative to advance understanding of diabetes and obesity through the National Centers for Metabolic Phenotyping in Live Models of Obesity and Diabetes (MPMOD). The MPMOD initiative provides access to advanced testing services, including bariatric surgery on mice, to enable new insights ...

Genetic causes of three previously unexplained rare diseases identified

Researchers at the Icahn School of Medicine at Mount Sinai identified previously unknown genetic causes of three rare diseases: primary lymphedema, thoracic aortic aneurysm disease, and congenital deafness. The study used a computational approach to analyze large genetic datasets from rare disease cohorts.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Medicine·TypeMeta-analysis·DateMar 16, 2023

Nara Sobreira, MD, PhD is the recipient of the 2023 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award from the ACMG Foundation for Genetic and Genomic Medicine

Dr. Nara Sobreira has developed innovative tools like GeneMatcher and VariantMatcher to aid in rare disease diagnosis, earning her the 2023 Watson Genetic Medicine Innovation Award. She continues to work on expanding genome analysis accessibility through education and research initiatives.

Alexander M. Holtz, MD, PhD receives the 2023 Richard King Award for Best Publication by a Trainee in Genetics in Medicine

Dr. Alexander M. Holtz received the award for his published article on heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies. The study highlights primary cilia-dependent defects in Hedgehog signaling, shedding light on a previously unknown autosomal dominant condition.

What ‘chornobyl dogs’ can tell us about survival in contaminated environments

Researchers studied genetic differences between two Chornobyl dog populations living near the nuclear power plant and 16.5 km away. They found significant genetic distinctions, with 391 outlier regions indicating potential genetic repair mechanisms. The study may provide insights into human adaptability to environmental disasters.

SourceColumbia University's Mailman School of Public Health·JournalCanine Medicine and Genetics·DateMar 8, 2023

Genes reveal kidney cancer’s risk of recurrence

A new study links genetic changes in kidney cancer to patient outcomes, identifying four groups of patients based on mutation presence. This research may lead to more effective prediction of recurrence risk and personalized treatment for thousands of patients annually.

SourceMcGill University·JournalClinical Cancer Research·TypeData/statistical analysis·DateFeb 23, 2023

Strata Oncology announces publication of study validating clinical utility of pan-tumor predictive biomarker for checkpoint inhibitor immunotherapy benefit

The study validated the clinical utility of Strata Oncology's proprietary pan-solid tumor predictive biomarker, Immunotherapy Response Score (IRS), which predicts response to checkpoint inhibitor therapy. IRS captures tumor biology and microenvironment by combining tumor mutation burden with quantitative expression of PD-L1, PD-1, ADAM...

SourceStrata Oncology·JournalCommunications Medicine·TypeData/statistical analysis·DateFeb 7, 2023

HKUMed discovers a diagnostic potential of the amniotic fluid cells RNA-sequencing in deciphering rare diseases

Researchers at HKUMed have established a baseline for gene expression profiles of amniotic fluid cells using RNA-sequencing, providing potential clinical utility for prenatal diagnosis. The study identified outliers in genes associated with structural congenital anomalies, offering new evidence for diagnosis.

SourceThe University of Hong Kong·JournalGenomic Medicine·TypeExperimental study·DateJan 3, 2023

Antibodies to common antibiotic possible new risk factor for type 1 diabetes

A study found that antibodies to common antibiotic gentamicin are associated with an increased risk of progression to type 1 diabetes in children already genetically at risk. The researchers also identified an association between the FUT2 gene and the production of these antibodies, which may be compounding risks for type 1 diabetes.

SourceMedical College of Georgia at Augusta University·JournalNature Communications·DateDec 8, 2022

A study on a rare disease helps to identify the mechanism that explains the appearance of head and neck tumors in the general population

A study published in Nature reveals that cells' inability to repair DNA damage caused by aldehydes increases the risk of developing head and neck tumors, particularly in patients with Fanconi anemia. The findings also suggest a link between smoking and drinking, which can lead to similar genetic mutations.

SourceInstitut de Recerca Sant Pau (Sant Pau Research Institute)·JournalNature·TypeObservational study·DateDec 7, 2022

When FMD hits a family, abdominal aortic aneurysms may too

Researchers discover a shared genetic basis between fibromuscular dysplasia (FMD) and abdominal aortic aneurysms (AAA), with males more likely to develop AAA when a family member has FMD. The study suggests that screening for AAA in male relatives of patients with FMD may be beneficial, along with established guidelines.

SourceMichigan Medicine - University of Michigan·JournalCirculation Genomic and Precision Medicine·TypeData/statistical analysis·DateDec 1, 2022

Making melanoma immortal: Pitt scientists discover key genetic step in cancer’s race to live forever

Researchers at the University of Pittsburgh School of Medicine have discovered a genetic link between melanoma tumors and telomere maintenance, which could lead to new treatments for the disease. The study found that mutations in the TPP1 gene stimulate telomerase activity, promoting long telomeres that enable cancer cells to divide in...

SourceUniversity of Pittsburgh·JournalScience·DateNov 10, 2022

Cleveland Clinic study identifies blood pressure drug as potential treatment for Black patients with Alzheimer’s disease

A new study published in Alzheimer's & Dementia found that telmisartan, a blood pressure medication, is associated with lower risk of Alzheimer's specifically in Black patients over 60. The study analyzed data from over 5 million patients and suggests that future clinical trials should prioritize minority populations to find or reinfor...

SourceCleveland Clinic·JournalAlzheimer s & Dementia·DateNov 4, 2022